Prevention of Macular Edema In Patients With Diabetic Retinopathy Undergoing Cataract Surgery
Status:
Completed
Trial end date:
2020-01-14
Target enrollment:
Participant gender:
Summary
To determine the safety and efficacy of intravitreal Aflibercept (Eylea) injection in
patients with diabetic retinopathy in the prevention of macular edema following cataract
surgery.